Apoptosis activated T- lymphocytes in induced sputum (IS) of patients with chronic obstructive bronchitis (COB) Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
The typing of cells in the induced sputum (IS) and its apoptosis in patients with chronic obstructive bronchitis (COB) Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002
Cell composition of induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB) Source: Eur Respir J 2001; 18: Suppl. 33, 368s Year: 2001
Concentration of NO2-, a-acid protein (AAP), tumor necrotic factor (TNF-a), in the induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB) Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
The typing of cells in the induced sputum (IS) and its apoptosis in patients with bronchial asthma (BA) Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Neutrophil chemokine receptor (CXCR1 and 2) gene expression and biopsy neutrophilia in severe exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis Source: Eur Respir J 2001; 18: Suppl. 33, 194s Year: 2001
Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Blood cytokine expression in patients with chronic obstructive airway diseases (COAD) Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Neutrophilic inflammation in nasal lavage (NL) and induced sputum (IS) from patients with chronic sinusitis or chronic sinusitis and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 455s Year: 2003
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006